The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016
The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Vaccines and monoclonal antibodies to protect the very young infant against the respiratory syncytial virus (RSV)-associated illness are effective for limited time periods. We aimed to estimate age-specific burden to guide implementation strategies and cost-effectiveness analyses.
We combined case-based surveillance and ecological data to genera...
Alternative Titles
Full title
The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_eef42780284b40748b2b496de214843b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eef42780284b40748b2b496de214843b
Other Identifiers
ISSN
1741-7015
E-ISSN
1741-7015
DOI
10.1186/s12916-023-02853-3
